Suppr超能文献

在人类多药耐药细胞系中扩增并过表达的基因。

Genes amplified and overexpressed in human multidrug-resistant cell lines.

作者信息

Van der Bliek A M, Baas F, Van der Velde-Koerts T, Biedler J L, Meyers M B, Ozols R F, Hamilton T C, Joenje H, Borst P

机构信息

Division of Molecular Biology, Netherlands Cancer Institute, Amsterdam.

出版信息

Cancer Res. 1988 Nov 1;48(21):5927-32.

PMID:2901906
Abstract

Multidrug resistance (MDR) is associated with overproduction of Mr 170,000 membrane proteins (P-glycoproteins) caused by either gene amplification, transcriptional activation, or both. In rodents the amplified domain comprises genes that encode P-glycoproteins and at least five unrelated genes, one of which encodes the calcium-binding protein sorcin. The amplification and increased expression of these genes always includes one P-glycoprotein-encoding gene (pgp1 in hamsters, homologous to mdr1 in humans). In human MDR cells only elevated mdr1 expression has been shown thusfar, although another P-glycoprotein encoding gene (mdr3, homologous to hamster pgp3) is closely linked. Here we show that the human homolog of the hamster sorcin gene resides on chromosome 7 like the P-glycoprotein-encoding genes. Furthermore, gene classes designated 4, 5, and 6 are coamplified with mdr1 and mdr3 in the human ovarian carcinoma cell line 2780AD, which strongly suggests that the overall structure of the human MDR domain is the same as in rodents. Class 6 was moderately and mdr1 was highly overexpressed in this cell line. Four other human MDR cell lines also have much higher mdr1 overexpression than expected from the relatively low levels (2- to 30-fold) of gene amplification. This contrasts with the results of previous work with rodent MDR cells, in which the increase in P-glycoprotein mRNA levels usually parallels the increase in gene copy number. Although four of the five human MDR cell lines have coamplified mdr3, its expression was undetectable. Our results confirm the central role of the mdr1 (pgp1) gene in MDR and suggest that different cross-resistance patterns are not due to differential expression of different P-glycoprotein genes.

摘要

多药耐药性(MDR)与由基因扩增、转录激活或两者共同作用导致的170,000道尔顿膜蛋白(P-糖蛋白)过度产生有关。在啮齿动物中,扩增区域包含编码P-糖蛋白的基因以及至少五个不相关的基因,其中一个基因编码钙结合蛋白索菌素。这些基因的扩增和表达增加总是包括一个编码P-糖蛋白的基因(仓鼠中的pgp1,与人类中的mdr1同源)。在人类MDR细胞中,迄今为止仅显示mdr1表达升高,尽管另一个编码P-糖蛋白的基因(mdr3,与仓鼠pgp3同源)紧密相连。在这里,我们表明仓鼠索菌素基因的人类同源物与编码P-糖蛋白的基因一样位于7号染色体上。此外,在人卵巢癌细胞系2780AD中,被命名为4、5和6类的基因与mdr1和mdr3共同扩增,这强烈表明人类MDR区域的整体结构与啮齿动物相同。在该细胞系中,6类基因适度过度表达,mdr1高度过度表达。其他四个人类MDR细胞系的mdr1过度表达也比基因扩增相对较低水平(2至30倍)预期的要高得多。这与先前对啮齿动物MDR细胞的研究结果形成对比,在啮齿动物MDR细胞中,P-糖蛋白mRNA水平的增加通常与基因拷贝数的增加平行。尽管五个人类MDR细胞系中有四个共同扩增了mdr3,但其表达无法检测到。我们的结果证实了mdr1(pgp1)基因在MDR中的核心作用,并表明不同的交叉耐药模式并非由于不同P-糖蛋白基因的差异表达所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验